IMVT — Immunovant
Median target
$50
calls from the last 12 months
Implied return
+32.8%
median target vs. price
Coverage
15 analysts · 16 calls
updated in the last 12 months
Consensus
13/2/0+13 net
Buy / Hold / Sell
Which analysts are behind IMVT's consensus?
See every current rating, price target and the analysts' track records for Immunovant — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 15 analysts with calls on IMVT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
IMVT elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-08-28 | Insiders | Pande AtulDirector | Insider sale | 1.5K sh @ $43.27 · planned trade | $65K |
| 2026-08-20 | Insiders | Gloria MelanieChief Operating Officer | Insider sale | 3.1K sh @ $44.16 | $135K |
| 2026-07-24 | Insiders | Pande AtulDirector | Insider sale | 1.5K sh @ $39.80 · planned trade | $60K |
| 2026-07-23 | Insiders | Girao TiagoChief Financial Officer | Insider sale | 6.8K sh @ $38.69 | $263K |
| 2026-07-23 | Insiders | Stout Jay SChief Technology Officer | Insider sale | 2.9K sh @ $38.69 | $111K |
| 2025-03-05 | Executive | Trump, Donald JPresident | Purchase | IMMUNOVANT INC | $15,001 - $500,003 |
More: insider activity · executive branch · trending